(19)
(11) EP 4 568 563 A1

(12)

(43) Date of publication:
18.06.2025 Bulletin 2025/25

(21) Application number: 23853380.6

(22) Date of filing: 10.08.2023
(51) International Patent Classification (IPC): 
A61B 5/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 5/4848; A61B 5/1451; A61B 5/14532; A61B 5/14546; A61B 5/14503; A61B 5/685; A61B 5/686
(86) International application number:
PCT/US2023/030025
(87) International publication number:
WO 2024/035903 (15.02.2024 Gazette 2024/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 10.08.2022 US 202263396811 P
30.09.2022 US 202263412044 P

(71) Applicant: University of Cincinnati
Cincinnati, OH 45206 (US)

(72) Inventors:
  • HEIKENFELD, Jason
    Cincinnati, OH 45202 (US)
  • WATKINS, Zachary Lee
    Cincinnati, OH 45202 (US)

(74) Representative: Reddie & Grose LLP 
The White Chapel Building 10 Whitechapel High Street
London E1 8QS
London E1 8QS (GB)

   


(54) BIOSENSOR SYSTEM FOR DRUG EFFICACY MONITORING